Rasio rega marang bathi Fulcrum Therapeutics Inc (FULC)

Fulcrum Therapeutics (FULC) minimizes technological threats by developing therapies for hereditary blood and muscle pathologies. The market trend on GURU.Markets demonstrates a -3.80 indicator, which correlates with a strategic pivot toward reducing research expenditures and seeking strategic allies. The primary growth drivers remain the losmapimod drug trials and potential merger and acquisition deals.

Koefisien rega marang bathi Fulcrum Corp (FULC): kanggo periode 04.07.2022 - 15.11.2026

Rincian metrik komprehensif lan analitis Fulcrum Therapeutics, Inc. (FULC)

- rega lan prakiraan konsensus rega:

Rega saham Fulcrum Therapeutics Inc|FULC - Bagan rega target

- rincian kapitalisasi pasar:

Nilai pasar Fulcrum Therapeutics Inc|FULC - Nilai Perusahaan

- informasi kapitalisasi buku:

Aset Bersih saben Saham Fulcrum Therapeutics|FULC - Aset Bersih Perusahaan|Kapitalisasi Pasar marang Aset Bersih fulcrumtx.com|FULC - Total Aset Perusahaan

- informasi babagan utang lan solvabilitas:

Utang marang Modal Fulcrum Therapeutics|FULC - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang modal Fulcrum Therapeutics, Inc.|FULC - Gunggung utang perusahaan|Rasio utang marang aset resik Fulcrum Tx|FULC - Utang jangka dawa perusahaan|Kewajiban jangka cendhak Fulcrum Therapeutics|Rasio jangkoan perantara fulcrumtx.com

- rincian bathi lan kelipatan pasar:

FULC - Bathi resik|Proyeksi bathi mangsa ngarep Fulcrum Therapeutics|FULC - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi Fulcrum Corp|FULC - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Fulcrum Therapeutics Inc|FULC - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Fulcrum Therapeutics|FULC - Bathi resik saben saham (EPS TTM)|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan fulcrumtx.com|FULC - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Fulcrum Therapeutics

- rincian pendapatan lan dodolan emiten:

FULC - Pendapatan perusahaan|Prakiraan pendapatan perusahaan Fulcrum Therapeutics, Inc.|FULC - Multiplikator P/S|Multiplikator forward rega marang pendapatan Fulcrum Tx|FULC - Wutah dodolan YoY sajrone rolas wulan kepungkur

Analisis umum perusahaan:Fulcrum Therapeutics Inc - FULC

Fulcrum Therapeutics (FULC) is accelerating the rollout of drugs for treating genetic blood disorders through partnerships with scientific centers. By analyzing the price-to-earnings ratio, an investor compares current market quotes with actual business performance to identify pricing anomalies. This metric's trend reflects the extent to which the asset is overvalued relative to its ability to generate net income. The company's final capitalization depends directly on the fundamental justification of this multiple.

Analisis perusahaan pesaing

Pangali P/E Vertex Pharmaceuticals Incorporated|Rasio rega marang bathi Alnylam Inc. (ALNY)|Rasio rega marang bathi INSM (Insmed Inc)|Pangali P/E UTHR (unither.com)|Periode bali modal bisnis BioMarin (BMRN)|BBIO: Koefisien rega marang bathi|Kapitalisasi marang bathi bgm.ltd|COGT: Pangali P/E|Kapitalisasi marang bathi Xeris Biopharma Inc (XERS)|KROS (Keros Therapeutics, Inc.) - Pangali P/E|Pangali rega marang bathi ARCT (Arcturus Therapeutics Holdings Inc.)|Koefisien rega marang bathi ETON (Eton Pharmaceuticals, Inc.)|KMDA (Kamada Ltd) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Abeona Therapeutics, Inc. ABEO|MREO (Mereo BioPharma Group PLC) - Kapitalisasi marang bathi resik|Protalix BioTherapeutics, Inc - Pangali P/E|Nilai perusahaan marang bathi resik PLRX (pliantrx.com)|APLT: Pangali P/E|Rein Therapeutics Inc. (RNTX) - Pangali P/E|Rasio rega marang bathi gelteq.com|AYTU: Nilai perusahaan marang bathi resik|Rasio rega marang bathi Chemomab Therapeutics Ltd (CMMB)|Koefisien rega marang bathi SRx Health Solutions SRXH|Pangali P/E PLRZ (Polyrizon Limited)|Pangali P/E Zentaris AEZS|Cyclo Therapeutics, Inc - Pangali P/E|Periode bali modal bisnis Inozyme Pharma INZY|RPHM: Pangali P/E|Kapitalisasi marang bathi cosciensbio.com (CSCI)